CN101670090A - 一种治疗中晚期恶性肿瘤的药物组合物及其制备方法 - Google Patents
一种治疗中晚期恶性肿瘤的药物组合物及其制备方法 Download PDFInfo
- Publication number
- CN101670090A CN101670090A CN200910300238A CN200910300238A CN101670090A CN 101670090 A CN101670090 A CN 101670090A CN 200910300238 A CN200910300238 A CN 200910300238A CN 200910300238 A CN200910300238 A CN 200910300238A CN 101670090 A CN101670090 A CN 101670090A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- pharmaceutical composition
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 44
- 201000011510 cancer Diseases 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000003814 drug Substances 0.000 claims abstract description 20
- 229940079593 drug Drugs 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 6
- 238000011282 treatment Methods 0.000 claims description 20
- 241000628997 Flos Species 0.000 claims description 15
- 210000000582 semen Anatomy 0.000 claims description 15
- 241000545442 Radix Species 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 9
- 241000605447 Anemarrhena Species 0.000 claims description 8
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 8
- 241001180876 Saposhnikovia Species 0.000 claims description 8
- 241000207929 Scutellaria Species 0.000 claims description 8
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 8
- 239000010271 massa medicata fermentata Substances 0.000 claims description 8
- 239000008517 radix Trichosanthis Substances 0.000 claims description 8
- 241000746375 Andrographis Species 0.000 claims description 7
- 241000555712 Forsythia Species 0.000 claims description 7
- 241000245240 Lonicera Species 0.000 claims description 7
- 239000006187 pill Substances 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 6
- 235000000177 Indigofera tinctoria Nutrition 0.000 claims description 5
- 241000612166 Lysimachia Species 0.000 claims description 5
- 229940097275 indigo Drugs 0.000 claims description 5
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 claims description 5
- 238000009472 formulation Methods 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 3
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims description 2
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 2
- 238000007796 conventional method Methods 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 13
- 238000002512 chemotherapy Methods 0.000 abstract description 6
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 3
- 230000003211 malignant effect Effects 0.000 abstract description 2
- 238000001959 radiotherapy Methods 0.000 abstract description 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000544270 Angelica acutiloba Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 241000234653 Cyperus Species 0.000 abstract 1
- 241001071917 Lithospermum Species 0.000 abstract 1
- 241001673966 Magnolia officinalis Species 0.000 abstract 1
- 240000000233 Melia azedarach Species 0.000 abstract 1
- 241000123069 Ocyurus chrysurus Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 244000153955 Reynoutria sachalinensis Species 0.000 abstract 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 241000218989 Trichosanthes Species 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 229910052602 gypsum Inorganic materials 0.000 abstract 1
- 239000010440 gypsum Substances 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 230000003203 everyday effect Effects 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 206010003445 Ascites Diseases 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 208000019425 cirrhosis of liver Diseases 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 230000001575 pathological effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 description 2
- 241000208125 Nicotiana Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 206010040007 Sense of oppression Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 230000001926 lymphatic effect Effects 0.000 description 2
- 210000005075 mammary gland Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 210000003101 oviduct Anatomy 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000002271 resection Methods 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016275 Fear Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000002151 Pleural effusion Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 208000037842 advanced-stage tumor Diseases 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 210000000742 appendix Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 238000011462 intraperitoneal chemotherapy Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000011645 metastatic carcinoma Diseases 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 201000010210 papillary cystadenocarcinoma Diseases 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 208000012991 uterine carcinoma Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009103002385A CN101670090B (zh) | 2009-01-16 | 2009-01-16 | 一种治疗中晚期恶性肿瘤的药物组合物及其制药用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009103002385A CN101670090B (zh) | 2009-01-16 | 2009-01-16 | 一种治疗中晚期恶性肿瘤的药物组合物及其制药用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101670090A true CN101670090A (zh) | 2010-03-17 |
CN101670090B CN101670090B (zh) | 2011-08-31 |
Family
ID=42017646
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009103002385A Expired - Fee Related CN101670090B (zh) | 2009-01-16 | 2009-01-16 | 一种治疗中晚期恶性肿瘤的药物组合物及其制药用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101670090B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102784244A (zh) * | 2012-07-26 | 2012-11-21 | 卢洪凡 | 一种治疗乳房肿块的中药外用药 |
CN103405663A (zh) * | 2013-07-10 | 2013-11-27 | 李俊萍 | 放疗辅助用中药组合物 |
CN103877508A (zh) * | 2014-03-28 | 2014-06-25 | 王俊杰 | 一种治疗子宫癌的中药组合物 |
CN104436054A (zh) * | 2014-12-10 | 2015-03-25 | 张�林 | 一种治疗直肠癌的中药 |
CN110507793A (zh) * | 2019-07-23 | 2019-11-29 | 广州伍氏神健康产业有限公司 | 一种用于治疗子宫癌、卵巢癌及肌瘤的组合药物及其制法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1194144A (zh) * | 1997-03-21 | 1998-09-30 | 职素琴 | 一种治疗癌症的外用膏药及其制作方法 |
US6790464B2 (en) * | 2003-01-16 | 2004-09-14 | Healthaid Enterprise Pte. Ltd. | Herbal compositions for prostate conditions |
-
2009
- 2009-01-16 CN CN2009103002385A patent/CN101670090B/zh not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102784244A (zh) * | 2012-07-26 | 2012-11-21 | 卢洪凡 | 一种治疗乳房肿块的中药外用药 |
CN102784244B (zh) * | 2012-07-26 | 2014-01-08 | 卢洪凡 | 一种治疗乳房肿块的中药外用药 |
CN103405663A (zh) * | 2013-07-10 | 2013-11-27 | 李俊萍 | 放疗辅助用中药组合物 |
CN103877508A (zh) * | 2014-03-28 | 2014-06-25 | 王俊杰 | 一种治疗子宫癌的中药组合物 |
CN104436054A (zh) * | 2014-12-10 | 2015-03-25 | 张�林 | 一种治疗直肠癌的中药 |
CN110507793A (zh) * | 2019-07-23 | 2019-11-29 | 广州伍氏神健康产业有限公司 | 一种用于治疗子宫癌、卵巢癌及肌瘤的组合药物及其制法 |
Also Published As
Publication number | Publication date |
---|---|
CN101670090B (zh) | 2011-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102847064B (zh) | 抑制恶性肿瘤转移的中药 | |
CN101822806B (zh) | 一种治疗肺癌的中药组合物及其制备方法 | |
CN102166317B (zh) | 一种治疗崩漏的中药组合物 | |
CN101683487A (zh) | 一种治疗食欲不振、消化不良及厌食的药物组合物及其制备方法 | |
CN101757562B (zh) | 一种治疗肝脏中期恶性肿瘤病证的中药组合物及其制备方法 | |
CN101670090B (zh) | 一种治疗中晚期恶性肿瘤的药物组合物及其制药用途 | |
CN102772737B (zh) | 用于治疗肝硬化纤维化的中药组合物及其制备方法 | |
CN102988879A (zh) | 一种治疗癌症的中药 | |
CN103316205B (zh) | 用于治疗缺铁性贫血的中药及制备方法 | |
CN107715067A (zh) | 一种调理血瘀体质的药物组合物及其制备方法和用途 | |
CN102671135B (zh) | 一种治疗卵巢囊肿的中药组合物及其制备方法 | |
CN101810823B (zh) | 一种治疗肾囊肿病证的中药组合物及其制备药物的用途 | |
CN103948782B (zh) | 一种治疗肝郁气滞型乳腺增生的药物组合物及其制备方法和用途 | |
CN102526676B (zh) | 治疗慢性心力衰竭的中药、制备方法及给药方式 | |
CN101342360B (zh) | 一种治疗食道癌的中药组合物 | |
CN103721196A (zh) | 一种治疗肝癌的中药组合物 | |
CN104225455A (zh) | 人体癌细胞逆转激活剂中药组合物 | |
CN103169745A (zh) | 治疗血尿的中药组合物及其用途 | |
CN1063651C (zh) | 辩证分型治疗癌症的水煎剂 | |
CN104623605A (zh) | 治疗乳腺癌的中药 | |
CN101375965B (zh) | 治疗进行期复发性银屑病的中药蜜丸 | |
CN110051812A (zh) | 一种扶正祛邪中药及其制备方法 | |
CN103479960A (zh) | 治疗慢性乙肝病的中草药 | |
CN101693096A (zh) | 一种治疗肝癌的药物及其制备方法 | |
CN101961416A (zh) | 一种治疗慢性前列腺炎的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: LU CHUNYAN Owner name: TAIYIHEPU(BEIJING) CHINESE MEDICINE RESEARCH INSTI Free format text: FORMER OWNER: WANG FENG Effective date: 20100329 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100071 2027B, NO.16-9, FENGGUAN ROAD, FENGTAI DISTRICT, BEIJING CITY TO: 100071 2027B,GUOMAO BUILDING, NO.16-9,WEST OF FENGGUAN ROAD, FENGTAI DISTRICT, BEIJING CITY |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20100329 Address after: 100071 Beijing Fengtai District Feng Line No. 16-9 Automall building 2027B Applicant after: Taiyihepu (Beijing) Research Institute of Chinese Medicine Co., Ltd. Address before: 100071, Beijing, Fengtai District, No. 16-9, 2027B Applicant before: Wang Feng Applicant before: Lu Chunyan |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110831 Termination date: 20140116 |